胸部CT中央型肿瘤位置是无淋巴结转移早期肺腺癌无病生存的不良预后因素
回顾性纳入2009至2015年单中心手术切除的病理T1a-bN0M0肺腺癌436例,评估两种中央型肺癌定义与无病生存的关系。定性定义(内1/3)调整HR为2.90,定量定义(内2/3)调整HR为2.77,后者时间依赖敏感度更高且阅片者间一致性更好。
要点
- CT上肿瘤位于肺内1/3(定性)或内2/3(定量)均与更差的无病生存独立相关。
- 定量定义(内2/3)阅片者间一致性κ=0.86,高于定性定义的κ=0.52。
- 定量定义时间依赖敏感度为48.2%,高于定性定义的15.1%。
核心结论
- 胸部CT定义的中央型肺癌(定性或定量)是无淋巴结转移早期肺腺癌的独立不良预后因素。
- 基于定量的定义在时间依赖敏感度和可重复性方面具有优势。
研究设计与样本
- 单中心回顾性研究,纳入2009至2015年间手术切除的病理T1a-bN0M0肺腺癌患者436例,中位年龄62岁(四分位距55-69岁),女性245例。
- 主要终点为无病生存,采用多变量Cox回归评估多种中央型肿瘤位置定义与生存的关联。
- 对每种定义评估时间依赖判别指标和阅片者间一致性。
诊断标准与关键数值
- 定性定义:CT上肿瘤位于由肺门发出的同心线所界定的肺内1/3为中央型,34例中央型中5例事件、402例外周型中27例事件,调整HR 2.90(95%CI 1.06-7.96,P=.04),阅片者间一致性Cohen κ=0.52(95%CI 0.37-0.68)。
- 定量定义:肿瘤位于肺内2/3为中央型,130例中央型中16例事件、306例外周型中16例事件,调整HR 2.77(95%CI 1.36-5.65,P=.005),阅片者间一致性Cohen κ=0.86(95%CI 0.80-0.91,P<.001)。
- 定量定义时间依赖敏感度48.2%(95%CI 28.8-67.6),定性定义15.1%(95%CI 1.3-28.9),P<.001。
临床应用与阅片要点
- 阅片时可参考由肺门发出同心线界定肺内1/3(定性)或内2/3(定量)的方法判断中央型位置。
- 定量定义(内2/3)阅片者间一致性更高(κ=0.86),时间依赖敏感度优于定性定义(48.2% vs 15.1%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The prognostic value of primary tumor location in the central lung is unclear because of heterogeneity in definitions of central lung cancer (CLC). Purpose To (a) validate the prognostic value of two recently proposed definitions of CLC by using a method designed to offset the shortcomings of existing evidence and (b) investigate the prognostic implications of a quantitative definition of CLC at chest CT. Materials and Methods Patients with pathologic stage T1a-bN0M0 lung adenocarcinomas resected between 2009 and 2015 at a single tertiary care center were retrospectively identified. The primary end point was disease-free survival. The associations of multiple definitions of central tumor location with survival were evaluated by using multivariable Cox regression. Time-dependent discrimination measures and interreader agreement were assessed for each definition. Results A total of 436 patients (median age, 62 years [interquartile range, 55-69 years]; 245 women) were evaluated. Tumor location at CT in the inner one-third of the lung defined by concentric lines arising from the hilum was adversely associated with survival (five events among 34 patients with CLC and 27 events among 402 patients with peripheral lung cancer; adjusted hazard ratio, 2.90 [95% CI: 1.06, 7.96; P = .04]) and showed moderate interreader agreement (Cohen κ = 0.52 [95% CI: 0.37, 0.68]). Quantitatively determined location in the inner two-thirds of the lung was also an independent prognostic factor (16 events among 130 patients with CLC and 16 events among 306 patients with peripheral lung cancer; adjusted hazard ratio, 2.77 [95% CI: 1.36, 5.65]; P = .005), with higher interreader agreement (Cohen κ = 0.86 [95% CI: 0.80, 0.91]; P < .001). The quantification-based definition exhibited higher time-dependent sensitivity (48.2% [14.27/29.61; 95% CI: 28.8, 67.6] vs 15.1% [4.47/29.61; 95% CI: 1.3, 28.9]; P < .001). Conclusion Central lung cancer at chest CT, defined qualitatively or quantitatively, is an independent adverse prognostic factor in patients with node-negative, early-stage lung adenocarcinomas. The quantification-based approach has advantages in terms of time-dependent sensitivity and reproducibility. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Wandtke and Hobbs in this issue.
引用
- Choi H, Kim H, Park CM, et al. Central Tumor Location at Chest CT Is an Adverse Prognostic Factor for Disease-Free Survival of Node-Negative Early-Stage Lung Adenocarcinomas. Radiology. 2021. PMID: 33620290. doi:10.1148/radiol.2021203937
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。